These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34660478)

  • 1. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
    Xu YM; Chu YQ; Wang H
    Front Pediatr; 2021; 9():704929. PubMed ID: 34660478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
    Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
    Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease.
    Yin QG; Zhou J; Zhou Q; Shen L; Zhang MY; Wu YH
    Front Pediatr; 2023; 11():1141158. PubMed ID: 37565244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.
    Tsai CM; Yu HR; Tang KS; Huang YH; Kuo HC
    Front Pediatr; 2020; 8():607631. PubMed ID: 33324592
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease.
    Xue M; Wang J
    Exp Ther Med; 2020 Apr; 19(4):2597-2603. PubMed ID: 32256739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease.
    Wang L; Zeng X; Chen B
    Medicine (Baltimore); 2023 Sep; 102(37):e34939. PubMed ID: 37713854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum plasminogen activator and D-dimer levels and the severity of Kawasaki disease in children as well as their predictive value for coronary artery lesion.
    Dou J; Zhao J; Lv Y; Jia H; Cao Y
    Am J Transl Res; 2024; 16(7):3240-3247. PubMed ID: 39114687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
    Zhang H; Song HB; Wang DX; Deng HY; Sun WL
    Pak J Med Sci; 2022; 38(5):1165-1169. PubMed ID: 35799766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between
    Liu X; Chen Y; Yang Y; Su Z; Wang F; Zhanghuang C; Wu Y; Zhang X
    Front Med (Lausanne); 2023; 10():1193303. PubMed ID: 37575991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.
    Cai WJ; Ding SG
    Medicine (Baltimore); 2022 Dec; 101(52):e32430. PubMed ID: 36596080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.
    Yang P; Mao Z; Sun M; Guo J
    Eur J Pediatr; 2023 Sep; 182(9):4049-4057. PubMed ID: 37394531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI Diagnosis of Coronary Artery Lesions in Children With Kawasaki Disease and Their Correlation With Inflammatory Factors.
    Liang J; Ma Y; Han N; Ai K; Zhang H; Zhang J
    J Magn Reson Imaging; 2024 Dec; 60(6):2369-2377. PubMed ID: 38415884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.
    Cho MA; Choi YJ; Jung JW
    Korean Circ J; 2010 Jun; 40(6):283-7. PubMed ID: 20589201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.